NMD4C, MDC and CSCN to Launch Clinical Fellowship Funding Competition

[updated February 3rd, 2022] The recipients of the funding competition have been announced – read the full press release!

The Neuromuscular Disease Network for Canada (NMD4C) together with Muscular Dystrophy Canada (MDC) and the Canadian Society of Clinical Neurophysiologists (CSCN) are excited to announce the launch of a funding competition to award three new national clinical fellowship awards in neuromuscular medicine and electromyography! 

The awards provide salary support for early-career clinicians to participate in a neuromuscular medicine and electromyography training program, with successful applicants being eligible to receive up to $76 500 in funding over a one-year period. 

 

“Through providing fellowship opportunities for residents to pursue high-quality clinical training in the field of neuromuscular medicine and electromyography, we will create a path to practice for talented clinicians with a passion for neuromuscular disease, raising the standard of treatment and access to care for all Canadians affected by neuromuscular disease.”

-Dr. Hanns Lochmüller, Lead Investigator, NMD4C

 

The competition opens on October 8th, 2021 with the deadline for submissions being November 19, 2021. The fellowship is open to Canadian citizens or permanent residents who have completed postgraduate training in adult or paediatric neurology or physiatry in a Royal College of Physicians and Surgeons of Canada accredited program at the time of commencement of the fellowship (at least one Canadian citizen/permanent resident will be awarded funding), and International/Canadian applicants who have completed postgraduate training in adult or paediatric neurology or physiatry outside of Canada that have met the Royal College of Physicians and Surgeons of Canada requirements, if they have the support of the proposed Canadian fellowship training director. We encourage all who are eligible to apply!

 

 

A total of three clinical fellowships will be awarded on a competitive basis for the 2022/2023 academic year. These fellowships have been made possible by generous supporters of Muscular Dystrophy Canada and an unrestricted educational grant from Grifols Canada.

 

“Finding a neuromuscular specialist is an important step in a person’s healthcare journey, and we know there are few specialists across the country. Physicians can foster an environment that supports effective and informed decision-making, which is central to person-and family centred care. Together with NMD4C and CSCN, we are building a pipeline of excellence and investing in top-ranked clinicians that will provide clinical care to those affected by neuromuscular disorders and help raise standards of care.”

– Stacey Lintern, CEO, MDC


The NMD4C and MDC are committed to empowering the next generation of  early-career researchers and clinicians in building successful careers in neuromuscular disease (NMD) research and clinical practice. When provided with access to research funding and clinical fellowship opportunities, researchers and clinicians are more likely to develop core competencies, perform meaningful research and make long-term commitments to the field of NMDs. 

 

Please don’t hesitate to share this opportunity with any of your colleagues and within your neuromuscular networks. For further inquiries, please contact Dr. Erin Beattie (NMD4C) at .

Please find the fellowship guidelines here.

Fellowship_Clinical_FB

Read next...

2024 Dr David Green Award winners from MDC

NMD4C Receive Excellence in Service Delivery Award and Network Investigators Honored as part of Muscular Dystrophy Canada’s 2024 Dr David Green Awards

We are excited to share that the NMD4C has been awarded the Excellence in Service Delivery Award, one of the annual Dr David Green Awards presented by Muscular Dystrophy Canada.

NMD4C logo with text reading 'Canadian neuromuscular clinical trials network', MDC and IMHA logos at bottom.

NMD4C Launch Canadian Neuromuscular Clinical Trial Network

We are thrilled to announce the launch of a Canadian neuromuscular clinical trial network (CTN) as a part of our clinical research work.

Event organizers and participants from SMA outcome measures training, March 2024 in Quebec.

Training Session for Physiotherapists and Occupational Therapists on Outcome Measures in Spinal muscular atrophy hosted by Quebec SMA Network

This past March 23, the Quebec SMA Network (Réseau québécois de l’amyotrophie spinale – RQAS) in collaboration with the NMD4C and Muscular Dystrophy Canada (MDC) hosted an interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal muscular atrophy (SMA). This training gathered clinicians to train and discuss SMA standardized outcome measures and work through current problems/challenges, to improve how these measures often tied to drug reimbursement are conducted. 

MDC award $900 000 towards clinical and translational research projects in 2024.

MDC Announce Recipients of 2024 Neuromuscular Clinical and Translational Research Grants

Muscular Dystrophy Canada (MDC) recently announced the recipients of its annual Neuromuscular Research Grants competition. Through these grants, MDC is investing $900,000 into clinical and translational research projects.

SMA outcome measures training graphic

SMA Outcome Measures Training for Physiotherapists and Occupational Therapists

To support the development and training on validated NMD outcome measures we are pleased to provide opportunities for physiotherapists and occupational therapists to attend training sessions for outcome measures.

Congratulations to the 2024 early career award winners. Dr Mireille Khacho and Dr Jean-Philippe Leduc Gaudet.

Congratulations to the 2024 NMD4C Early Career Awards Recipients

We are excited to announce the recipients of the 2024 NMD4C Early Career Awards! This is the second year of our annual award program, celebrating excellence and contribution to the neuromuscular field from early career investigators across both clinical and basic science streams.